PMC/PubMed Indexed Articles
Indexed In
- Online Access to Research in the Environment (OARE)
- Open J Gate
- Genamics JournalSeek
- JournalTOCs
- Scimago
- Ulrich's Periodicals Directory
- Access to Global Online Research in Agriculture (AGORA)
- Electronic Journals Library
- Centre for Agriculture and Biosciences International (CABI)
- RefSeek
- Directory of Research Journal Indexing (DRJI)
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Scholarsteer
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- MIAR
- University Grants Commission
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Abstract
Growth, Reproduction and Sex Ratios in Oreochromis Andersonii (Castelnau, 1861) Fed with Varying Levels of 17α-Methyl Testosterone
Kefi AS, Kang’ombe J, Kassam D and Katongo C
Three different doses (40, 60 and 90 mgMT/kg feed) of 17α-methyl testosterone (MT) were administered to Oreochromis andersonii. Growth, reproduction and sex ratios were evaluated. The fish raised on 60 mgMT/kg feed had the highest final mean weight and this was significantly different (P<0.05) from other hormone doses. Additionally, the 60 mgMT/kg fed fish had the lowest fecundity and reproductive effort. Histological examination of the gonads did not show any differences between the control and MT fed fish. The gross margin ratio (GMR) of the control group was the highest (P<0.05). The proportion of males in MT treated groups deviated significantly from the control group although the percentage of males obtained from the 40 mgMT/kg feed (93.4%) and 60 mgMT/kg feed (94.4%) fish was insignificant (P>0.05). Furthermore, the highest dose used produced a significantly lower (P<0.05) male proportion (79.3%) than the other treatments. The anabolic effect of androgen MT diminished over time.